{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:44:57Z","timestamp":1786981497574,"version":"build-2736575974"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460091"],"award-info":[{"award-number":["82460091"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460250"],"award-info":[{"award-number":["82460250"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangxi Provincial Health Technology Project","award":["202410011"],"award-info":[{"award-number":["202410011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-025-11425-y","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:18:29Z","timestamp":1767705509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Endothelial-Mesenchymal transition in cerebrovascular diseases: molecular mechanisms and promising pharmacological strategies"],"prefix":"10.1007","volume":"53","author":[{"given":"Jinlin","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianda","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daya","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erming","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"11425_CR1","doi-asserted-by":"publisher","first-page":"1023679","DOI":"10.3389\/fnagi.2022.1023679","volume":"14","author":"M Chen","year":"2022","unstructured":"Chen M, Zhang H, Chu YH et al (2022) Microglial autophagy in cerebrovascular diseases. Front Aging Neurosci 14:1023679","journal-title":"Front Aging Neurosci"},{"key":"11425_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.567682","volume":"8","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Yang X (2020) The roles of TGF-beta signaling in cerebrovascular diseases. Front Cell Dev Biol 8:567682","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"11425_CR3","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","volume":"163","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Nelson AR, Betsholtz C, Zlokovic BV (2015) Establishment and dysfunction of the blood-brain barrier. Cell 163(5):1064\u20131078","journal-title":"Cell"},{"issue":"2","key":"11425_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10456-021-09785-7","volume":"24","author":"C Marziano","year":"2021","unstructured":"Marziano C, Genet G, Hirschi KK (2021) Vascular endothelial cell specification in health and disease. Angiogenesis 24(2):213\u2013236","journal-title":"Angiogenesis"},{"issue":"12","key":"11425_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cells12121640","volume":"12","author":"J Immanuel","year":"2023","unstructured":"Immanuel J, Yun S (2023) Vascular inflammatory diseases and endothelial phenotypes. Cells 12(12):1601","journal-title":"Cells"},{"issue":"1","key":"11425_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/BOR.0000000000000963","volume":"36","author":"E Romano","year":"2024","unstructured":"Romano E, Rosa I, Fioretto BS, Manetti M (2024) The contribution of endothelial cells to tissue fibrosis. Curr Opin Rheumatol 36(1):52\u201360","journal-title":"Curr Opin Rheumatol"},{"key":"11425_CR7","doi-asserted-by":"crossref","unstructured":"Simons M (2023) Endothelial-to-mesenchymal transition: advances and controversies. Curr Opin Physiol 34:100677","DOI":"10.1016\/j.cophys.2023.100678"},{"issue":"1","key":"11425_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-021-00186-3","volume":"42","author":"Y Yoshimatsu","year":"2022","unstructured":"Yoshimatsu Y, Watabe T (2022) Emerging roles of inflammation-mediated endothelial-mesenchymal transition in health and disease. Inflamm Regen 42(1):9","journal-title":"Inflamm Regen"},{"issue":"2","key":"11425_CR9","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1152\/physrev.00021.2018","volume":"99","author":"S Piera-Velazquez","year":"2019","unstructured":"Piera-Velazquez S, Jimenez SA (2019) Endothelial to mesenchymal transition: role in physiology and in the pathogenesis of human diseases. Physiol Rev 99(2):1281\u20131324","journal-title":"Physiol Rev"},{"issue":"Suppl 1","key":"11425_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/1755-1536-5-S1-S7","volume":"5","author":"S Piera-Velazquez","year":"2012","unstructured":"Piera-Velazquez S, Jimenez SA (2012) Molecular mechanisms of endothelial to mesenchymal cell transition (EndoMT) in experimentally induced fibrotic diseases. Fibrogenesis Tissue Repair 5(Suppl 1):S7","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"3","key":"11425_CR11","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.ajpath.2011.06.001","volume":"179","author":"S Piera-Velazquez","year":"2011","unstructured":"Piera-Velazquez S, Li Z, Jimenez SA (2011) Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol 179(3):1074\u20131080","journal-title":"Am J Pathol"},{"issue":"3","key":"11425_CR12","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/dvdy.24589","volume":"247","author":"G Sanchez-Duffhues","year":"2018","unstructured":"Sanchez-Duffhues G, Garcia DVA, Ten DP (2018) Endothelial-to-mesenchymal transition in cardiovascular diseases: developmental signaling pathways gone awry. Dev Dyn 247(3):492\u2013508","journal-title":"Dev Dyn"},{"issue":"3","key":"11425_CR13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/path.4653","volume":"238","author":"G Sanchez-Duffhues","year":"2016","unstructured":"Sanchez-Duffhues G, Orlova V, Ten DP (2016) In brief: endothelial-to-mesenchymal transition. J Pathol 238(3):378\u2013380","journal-title":"J Pathol"},{"issue":"2","key":"11425_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1161\/ATVBAHA.114.303220","volume":"35","author":"KM Welch-Reardon","year":"2015","unstructured":"Welch-Reardon KM, Wu N, Hughes CC (2015) A role for partial endothelial-mesenchymal transitions in angiogenesis? Arterioscler Thromb Vasc Biol 35(2):303\u2013308","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"11425_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cells11111834","author":"Q Peng","year":"2022","unstructured":"Peng Q, Shan D, Cui K et al (2022) The role of endothelial-to-mesenchymal transition in cardiovascular disease. Cells 11(11):1847","journal-title":"Cells"},{"issue":"1","key":"11425_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/path.4814","volume":"241","author":"L Xiao","year":"2017","unstructured":"Xiao L, Dudley AC (2017) Fine-tuning vascular fate during endothelial-mesenchymal transition. J Pathol 241(1):25\u201335","journal-title":"J Pathol"},{"issue":"19","key":"11425_CR17","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","volume":"186","author":"J Massague","year":"2023","unstructured":"Massague J, Sheppard D (2023) TGF-beta signaling in health and disease. Cell 186(19):4007\u20134037","journal-title":"Cell"},{"key":"11425_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.semcancer.2023.04.007","volume":"92","author":"T Watabe","year":"2023","unstructured":"Watabe T, Takahashi K, Pietras K, Yoshimatsu Y (2023) Roles of TGF-beta signals in tumor microenvironment via regulation of the formation and plasticity of vascular system. Semin Cancer Biol 92:130\u2013138","journal-title":"Semin Cancer Biol"},{"key":"11425_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1113061","volume":"10","author":"PY Chen","year":"2023","unstructured":"Chen PY, Qin L, Simons M (2023) TGFbeta signaling pathways in human health and disease. Front Mol Biosci 10:1113061","journal-title":"Front Mol Biosci"},{"key":"11425_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114576","volume":"162","author":"E Podyacheva","year":"2023","unstructured":"Podyacheva E, Danilchuk M, Toropova Y (2023) Molecular mechanisms of endothelial remodeling under doxorubicin treatment. Biomed Pharmacother 162:114576","journal-title":"Biomed Pharmacother"},{"key":"11425_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115579","volume":"213","author":"D Lu","year":"2023","unstructured":"Lu D, Jiang H, Zou T et al (2023) Endothelial-to-mesenchymal transition: new insights into vascular calcification. Biochem Pharmacol 213:115579","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"11425_CR22","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1002\/art.34444","volume":"64","author":"A Horn","year":"2012","unstructured":"Horn A, Palumbo K, Cordazzo C et al (2012) Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis. Arthritis Rheum 64(8):2724\u201333","journal-title":"Arthritis Rheum"},{"key":"11425_CR23","doi-asserted-by":"crossref","unstructured":"Sweeney M, O\u2019Fee K, Villanueva-Hayes C et al (2023) Cardiomyocyte-Restricted expression of IL11 causes cardiac Fibrosis, Inflammation, and dysfunction. Int J Mol Sci 24(16):12823","DOI":"10.3390\/ijms241612989"},{"key":"11425_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2025.107463","volume":"158","author":"G Querio","year":"2025","unstructured":"Querio G, Geddo F, Antoniotti S et al (2025) Stay connected: the myoendothelial junction proteins in vascular function and dysfunction. Vascul Pharmacol 158:107463","journal-title":"Vascul Pharmacol"},{"issue":"3","key":"11425_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14030256","volume":"14","author":"C Penna","year":"2025","unstructured":"Penna C, Pagliaro P (2025) Endothelial dysfunction: redox imbalance, NLRP3 inflammasome, and inflammatory responses in cardiovascular diseases. Antioxidants 14(3):256","journal-title":"Antioxidants"},{"key":"11425_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1146\/annurev-physiol-032222-080806","volume":"85","author":"Y Xu","year":"2023","unstructured":"Xu Y, Kovacic JC (2023) Endothelial to mesenchymal transition in health and disease. Annu Rev Physiol 85:245\u2013267","journal-title":"Annu Rev Physiol"},{"issue":"5","key":"11425_CR27","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41419-021-03750-4","volume":"12","author":"L Zhang","year":"2021","unstructured":"Zhang L, He J, Wang J et al (2021) Knockout RAGE alleviates cardiac fibrosis through repressing endothelial-to-mesenchymal transition (EndMT) mediated by autophagy. Cell Death Dis 12(5):470","journal-title":"Cell Death Dis"},{"key":"11425_CR28","doi-asserted-by":"publisher","first-page":"1022988","DOI":"10.3389\/fcvm.2022.1022988","volume":"9","author":"Q Jun","year":"2022","unstructured":"Jun Q, Youhong L, Yuan Z et al (2022) Histone modification of endothelial-mesenchymal transition in cardiovascular diseases. Front Cardiovasc Med 9:1022988","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"11425_CR29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3171\/2011.8.JNS101241","volume":"116","author":"DD Cavalcanti","year":"2012","unstructured":"Cavalcanti DD, Kalani MY, Martirosyan NL et al (2012) Cerebral cavernous malformations: from genes to proteins to disease. J Neurosurg 116(1):122\u201332","journal-title":"J Neurosurg"},{"issue":"11","key":"11425_CR30","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.15252\/emmm.201505316","volume":"7","author":"S Marchi","year":"2015","unstructured":"Marchi S, Corricelli M, Trapani E et al (2015) Defective autophagy is a key feature of cerebral cavernous malformations. EMBO Mol Med 7(11):1403\u20131417","journal-title":"EMBO Mol Med"},{"issue":"7\u20139","key":"11425_CR31","first-page":"496","volume":"38","author":"A Perrelli","year":"2023","unstructured":"Perrelli A, Ferraris C, Berni E, Glading AJ, Retta SF (2023) KRIT1: a traffic warden at the busy crossroads between redox signaling and the pathogenesis of cerebral cavernous malformation disease. Antioxid Redox Signal 38(7\u20139):496\u2013528","journal-title":"Antioxid Redox Signal"},{"issue":"7455","key":"11425_CR32","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature12207","volume":"498","author":"L Maddaluno","year":"2013","unstructured":"Maddaluno L, Rudini N, Cuttano R et al (2013) EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 498(7455):492\u2013496","journal-title":"Nature"},{"issue":"27","key":"11425_CR33","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.1073\/pnas.1501352112","volume":"112","author":"L Bravi","year":"2015","unstructured":"Bravi L, Rudini N, Cuttano R et al (2015) Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice. Proc Natl Acad Sci U S A 112(27):8421\u20136","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"11425_CR34","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1161\/STROKEAHA.115.011867","volume":"47","author":"L Bravi","year":"2016","unstructured":"Bravi L, Malinverno M, Pisati F et al (2016) Endothelial cells lining sporadic cerebral cavernous malformation cavernomas undergo endothelial-to-mesenchymal transition. Stroke 47(3):886\u2013890","journal-title":"Stroke"},{"issue":"1","key":"11425_CR35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/neuros\/nyx078","volume":"81","author":"S Takada","year":"2017","unstructured":"Takada S, Hojo M, Tanigaki K, Miyamoto S (2017) Contribution of endothelial-to-mesenchymal transition to the pathogenesis of human cerebral and orbital cavernous malformations. Neurosurgery 81(1):176\u2013183","journal-title":"Neurosurgery"},{"issue":"1","key":"11425_CR36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.15252\/emmm.201505433","volume":"8","author":"R Cuttano","year":"2016","unstructured":"Cuttano R, Rudini N, Bravi L et al (2016) KLF4 is a key determinant in the development and progression of cerebral cavernous malformations. EMBO Mol Med 8(1):6\u201324","journal-title":"EMBO Mol Med"},{"issue":"7597","key":"11425_CR37","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature17178","volume":"532","author":"Z Zhou","year":"2016","unstructured":"Zhou Z, Tang AT, Wong WY et al (2016) Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2\/4 signalling. Nature 532(7597):122\u2013126","journal-title":"Nature"},{"issue":"11","key":"11425_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2019.07.013","volume":"1865","author":"J Li","year":"2019","unstructured":"Li J, Zhao Y, Coleman P et al (2019) Low fluid shear stress conditions contribute to activation of cerebral cavernous malformation signalling pathways. Biochimica et Biophysica Acta (BBA) 1865(11):165519","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"1","key":"11425_CR39","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41467-020-20774-0","volume":"12","author":"HJ Zhou","year":"2021","unstructured":"Zhou HJ, Qin L, Jiang Q et al (2021) Caveolae-mediated Tie2 signaling contributes to CCM pathogenesis in a brain endothelial cell-specific Pdcd10-deficient mouse model. Nat Commun 12(1):504","journal-title":"Nat Commun"},{"issue":"3","key":"11425_CR40","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s12276-023-00962-w","volume":"55","author":"J Ren","year":"2023","unstructured":"Ren J, Xiao X, Li R et al (2023) Single-cell sequencing reveals that endothelial cells, EndMT cells and mural cells contribute to the pathogenesis of cavernous malformations. Exp Mol Med 55(3):628\u2013642","journal-title":"Exp Mol Med"},{"issue":"1","key":"11425_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12964-023-01301-2","volume":"22","author":"Y Li","year":"2024","unstructured":"Li Y, Girard R, Srinath A et al (2024) Transcriptomic signatures of individual cell types in cerebral cavernous malformation. Cell Commun Signal 22(1):23","journal-title":"Cell Commun Signal"},{"key":"11425_CR42","doi-asserted-by":"publisher","first-page":"15008","DOI":"10.1038\/nrdp.2015.8","volume":"1","author":"MT Lawton","year":"2015","unstructured":"Lawton MT, Rutledge WC, Kim H et al (2015) Brain arteriovenous malformations. Nat Rev Dis Primers 1:15008","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"11425_CR43","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1172\/JCI125965","volume":"129","author":"J Yao","year":"2019","unstructured":"Yao J, Wu X, Zhang D et al (2019) Elevated endothelial Sox2 causes lumen disruption and cerebral arteriovenous malformations. J Clin Invest 129(8):3121\u20133133","journal-title":"J Clin Invest"},{"issue":"2","key":"11425_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.99","volume":"10","author":"LD Shoemaker","year":"2020","unstructured":"Shoemaker LD, McCormick AK, Allen BM, Chang SD (2020) Evidence for endothelial-to-mesenchymal transition in human brain arteriovenous malformations. Clin Transl Med 10(2):e99","journal-title":"Clin Transl Med"},{"issue":"9","key":"11425_CR45","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1161\/CIRCRESAHA.121.319004","volume":"129","author":"H Li","year":"2021","unstructured":"Li H, Nam Y, Huo R et al (2021) De novo germline and somatic variants convergently promote endothelial-to-mesenchymal transition in simplex brain arteriovenous malformation. Circ Res 129(9):825\u2013839","journal-title":"Circ Res"},{"issue":"3","key":"11425_CR46","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1136\/svn-2022-001700","volume":"8","author":"H Xu","year":"2023","unstructured":"Xu H, Huo R, Li H et al (2023) KRAS mutation-induced EndMT of brain arteriovenous malformation is mediated through the TGF-beta\/BMP-SMAD4 pathway. Stroke Vasc Neurol 8(3):197\u2013206","journal-title":"Stroke Vasc Neurol"},{"issue":"1","key":"11425_CR47","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s11658-023-00436-x","volume":"28","author":"CL Karthika","year":"2023","unstructured":"Karthika CL, Venugopal V, Sreelakshmi BJ et al (2023) Oscillatory shear stress modulates Notch-mediated endothelial mesenchymal plasticity in cerebral arteriovenous malformations. Cell Mol Biol Lett 28(1):22","journal-title":"Cell Mol Biol Lett"},{"issue":"5","key":"11425_CR48","doi-asserted-by":"publisher","first-page":"e26748","DOI":"10.1016\/j.heliyon.2024.e26748","volume":"10","author":"J Liu","year":"2024","unstructured":"Liu J, Chen C, Qin X et al (2024) Plasma-derived exosomes contributes to endothelial-to-mesenchymal transition in Moyamoya disease. Heliyon 10(5):e26748","journal-title":"Heliyon"},{"issue":"5","key":"11425_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.525","volume":"5","author":"Q He","year":"2024","unstructured":"He Q, Li J, Tao C et al (2024) High glutamine increases stroke risk by inducing the endothelial-to-mesenchymal transition in moyamoya disease. MedComm 5(5):e525","journal-title":"MedComm"},{"issue":"1","key":"11425_CR50","volume":"61","author":"J Li","year":"2024","unstructured":"Li J, He Q, Zheng Z et al (2024) Comprehensive analysis and in vitro verification of endothelial-mesenchymal transition-related genes in moyamoya disease. Mol Neurobiol 61(1):337\u2013351","journal-title":"Mol Neurobiol"},{"issue":"4","key":"11425_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1647","volume":"14","author":"P Ge","year":"2024","unstructured":"Ge P, Tao C, Wang W et al (2024) Circulating immune cell landscape and T-cell abnormalities in patients with moyamoya disease. Clin Transl Med 14(4):e1647","journal-title":"Clin Transl Med"},{"issue":"3","key":"11425_CR52","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3174\/ajnr.A2339","volume":"32","author":"Z Kulcsar","year":"2011","unstructured":"Kulcsar Z, Ugron A, Marosfoi M et al (2011) Hemodynamics of cerebral aneurysm initiation: the role of wall shear stress and Spatial wall shear stress gradient. AJNR Am J Neuroradiol 32(3):587\u2013594","journal-title":"AJNR Am J Neuroradiol"},{"key":"11425_CR53","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1016\/j.wneu.2023.05.056","volume":"176","author":"L Cheng","year":"2023","unstructured":"Cheng L, Huang Y, Yao H et al (2023) Wall shear stress reduction activates angiotensin II to facilitate aneurysmal subarachnoid hemorrhage in intracranial aneurysms through MicroRNA-29\/The growth factor-beta receptor type II\/Smad3 axis. World Neurosurg 176:e314\u2013e326","journal-title":"World Neurosurg"},{"issue":"4","key":"11425_CR54","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10014-018-0323-2","volume":"35","author":"S Takada","year":"2018","unstructured":"Takada S, Hojo M, Takebe N, Tanigaki K, Miyamoto S (2018) Stromal cells of hemangioblastomas exhibit mesenchymal stem cell-derived vascular progenitor cell properties. Brain Tumor Pathol 35(4):193\u2013201","journal-title":"Brain Tumor Pathol"},{"key":"11425_CR55","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1016\/j.wneu.2018.05.235","volume":"117","author":"S Takada","year":"2018","unstructured":"Takada S, Hojo M, Takebe N, Tanigaki K, Miyamoto S (2018) Role of Endothelial-to-Mesenchymal transition in the pathogenesis of central nervous system hemangioblastomas. World Neurosurg 117:e187\u2013e193","journal-title":"World Neurosurg"},{"issue":"29","key":"11425_CR56","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1093\/eurheartj\/ehad397","volume":"44","author":"G Liuzzo","year":"2023","unstructured":"Liuzzo G, Pedicino D (2023) Simvastatin rescues vascular health by targeting epigenetic-regulated endothelial-to-mesenchymal transition: a revival of pleiotropic effects? Eur Heart J 44(29):2657\u20132658","journal-title":"Eur Heart J"},{"issue":"10","key":"11425_CR57","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1161\/CIRCULATIONAHA.110.005249","volume":"124","author":"R Tuuminen","year":"2011","unstructured":"Tuuminen R, Syrjala S, Krebs R et al (2011) Donor simvastatin treatment abolishes rat cardiac allograft ischemia\/reperfusion injury and chronic rejection through microvascular protection. Circulation 124(10):1138\u20131150","journal-title":"Circulation"},{"key":"11425_CR58","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3389\/fphar.2017.00473","volume":"8","author":"Z Ma","year":"2017","unstructured":"Ma Z, Zhu L, Liu Y et al (2017) Lovastatin alleviates Endothelial-to-Mesenchymal transition in glomeruli via suppression of oxidative stress and TGF-beta1 signaling. Front Pharmacol 8:473","journal-title":"Front Pharmacol"},{"issue":"9","key":"11425_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2025.03.014","volume":"10","author":"D Diaz-Gil","year":"2025","unstructured":"Diaz-Gil D, Gierlinger G, Silva-Gomez N et al (2025) Preclinical assessment of atorvastatin for treatment of endocardial fibroelastosis. JACC. Basic to translational science 10(9):101282","journal-title":"JACC. Basic to translational science"},{"issue":"10","key":"11425_CR60","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.jacc.2017.07.734","volume":"70","author":"PE Bartko","year":"2017","unstructured":"Bartko PE, Dal-Bianco JP, Guerrero JL et al (2017) Effect of losartan on mitral valve changes after myocardial infarction. J Am Coll Cardiol 70(10):1232\u20131244","journal-title":"J Am Coll Cardiol"},{"key":"11425_CR61","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3389\/fphar.2018.01213","volume":"9","author":"Y Yao","year":"2018","unstructured":"Yao Y, Li Y, Zeng X et al (2018) Losartan alleviates renal fibrosis and inhibits Endothelial-to-Mesenchymal transition (EMT) under High-Fat Diet-Induced hyperglycemia. Front Pharmacol 9:1213","journal-title":"Front Pharmacol"},{"issue":"1","key":"11425_CR62","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000374063","volume":"36","author":"X Chen","year":"2015","unstructured":"Chen X, Cai J, Zhou X et al (2015) Protective effect of spironolactone on Endothelial-to-Mesenchymal transition in HUVECs via Notch pathway. Cell Physiol Biochem 36(1):191\u2013200","journal-title":"Cell Physiol Biochem"},{"key":"11425_CR63","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.2147\/DDDT.S100095","volume":"10","author":"H Zhou","year":"2016","unstructured":"Zhou H, Xi D, Liu J et al (2016) Spirolactone provides protection from renal fibrosis by inhibiting the endothelial-mesenchymal transition in isoprenaline-induced heart failure in rats. Drug Des Devel Ther 10:1581\u20131588","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"11425_CR64","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1159\/000464125","volume":"41","author":"J Cai","year":"2017","unstructured":"Cai J, Chen X, Chen X et al (2017) Anti-fibrosis effect of relaxin and spironolactone combined on isoprenaline-induced myocardial fibrosis in rats via inhibition of endothelial-mesenchymal transition. Cell Physiol Biochem 41(3):1167\u20131178","journal-title":"Cell Physiol Biochem"},{"issue":"Pt 6","key":"11425_CR65","doi-asserted-by":"publisher","first-page":"127312","DOI":"10.1016\/j.ijbiomac.2023.127312","volume":"253","author":"Y Wu","year":"2023","unstructured":"Wu Y, Zhang J, Mu T et al (2023) Selection of goat beta-casein derived ACE-inhibitory peptide SQPK and insights into its effect and regulatory mechanism on the function of endothelial cells. Int J Biol Macromol 253(Pt 6):127312","journal-title":"Int J Biol Macromol"},{"issue":"11 Pt A","key":"11425_CR66","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/j.bbagen.2016.07.010","volume":"1860","author":"G Ambrozova","year":"2016","unstructured":"Ambrozova G, Fidlerova T, Verescakova H et al (2016) Nitro-oleic acid inhibits vascular endothelial inflammatory responses and the endothelial-mesenchymal transition. Biochim Biophys Acta 1860(11 Pt A):2428\u20132437","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"11425_CR67","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/s41374-018-0080-1","volume":"98","author":"J Xu","year":"2018","unstructured":"Xu J, Wang J, He M et al (2018) Dipeptidyl peptidase IV (DPP-4) inhibition alleviates pulmonary arterial remodeling in experimental pulmonary hypertension. Lab Invest 98(10):1333\u20131346","journal-title":"Lab Invest"},{"key":"11425_CR68","volume":"2018","author":"J Xu","year":"2018","unstructured":"Xu J, Wang J, Cheng Y et al (2018) Glucagon-like peptide-1 mediates the protective effect of the dipeptidyl peptidase IV inhibitor on renal fibrosis via reducing the phenotypic conversion of renal microvascular cells in monocrotaline-treated rats. BioMed Res Int 2018:1864107","journal-title":"BioMed Res Int"},{"issue":"6","key":"11425_CR69","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.2337\/db13-1029","volume":"63","author":"K Kanasaki","year":"2014","unstructured":"Kanasaki K, Shi S, Kanasaki M et al (2014) Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen. Diabetes 63(6):2120\u20132131","journal-title":"Diabetes"},{"issue":"4","key":"11425_CR70","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s11010-021-04349-1","volume":"477","author":"B Pei","year":"2022","unstructured":"Pei B, Zhang N, Pang T, Sun G (2022) Linagliptin ameliorates pulmonary fibrosis in systemic sclerosis mouse model via inhibition of endothelial-to-mesenchymal transition. Mol Cell Biochem 477(4):995\u20131007","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"11425_CR71","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12931-017-0660-4","volume":"18","author":"T Suzuki","year":"2017","unstructured":"Suzuki T, Tada Y, Gladson S et al (2017) Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition. Respir Res 18(1):177","journal-title":"Respir Res"},{"issue":"1","key":"11425_CR72","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12929-019-0496-y","volume":"26","author":"J Wang","year":"2019","unstructured":"Wang J, Yu M, Xu J et al (2019) Glucagon-like peptide-1 (GLP-1) mediates the protective effects of dipeptidyl peptidase IV inhibition on pulmonary hypertension. J Biomed Sci 26(1):6","journal-title":"J Biomed Sci"},{"issue":"6","key":"11425_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/cells8060589","volume":"8","author":"TH Tsai","year":"2019","unstructured":"Tsai TH, Lee CH, Cheng CI et al (2019) Liraglutide inhibits endothelial-to-mesenchymal transition and attenuates neointima formation after endovascular injury in streptozotocin-induced diabetic mice. Cells 8(6):589","journal-title":"Cells"},{"issue":"16","key":"11425_CR74","doi-asserted-by":"publisher","first-page":"7642","DOI":"10.1111\/jcmm.16601","volume":"25","author":"J Tian","year":"2021","unstructured":"Tian J, Zhang M, Suo M et al (2021) Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKalpha\/TGF-beta\/Smad signalling in type 2 diabetic rats. J Cell Mol Med 25(16):7642\u20137659","journal-title":"J Cell Mol Med"},{"key":"11425_CR75","doi-asserted-by":"publisher","first-page":"175826","DOI":"10.1016\/j.ejphar.2023.175826","volume":"954","author":"W Zhang","year":"2023","unstructured":"Zhang W, Li X, Li M et al (2023) Empagliflozin inhibits neointimal hyperplasia through attenuating endothelial-to-mesenchymal transition via TAK-1\/NF-kappaB pathway. Eur J Pharmacol 954:175826","journal-title":"Eur J Pharmacol"},{"key":"11425_CR76","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jare.2022.02.017","volume":"43","author":"CK Cheng","year":"2023","unstructured":"Cheng CK, Lin X, Pu Y et al (2023) SOX4 is a novel phenotypic regulator of endothelial cells in atherosclerosis revealed by single-cell analysis. J Adv Res 43:187\u2013203","journal-title":"J Adv Res"},{"key":"11425_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110812","volume":"110","author":"G Dong","year":"2023","unstructured":"Dong G, Huang X, Xu Y, Chen R, Chen S (2023) Mechanical stress induced EndoMT in endothelial cells through PPARgamma downregulation. Cell Signal 110:110812","journal-title":"Cell Signal"},{"key":"11425_CR78","first-page":"3406","volume":"17","author":"H Gao","year":"2011","unstructured":"Gao H, Zhang J, Liu T, Shi W (2011) Rapamycin prevents endothelial cell migration by inhibiting the endothelial-to-mesenchymal transition and matrix metalloproteinase-2 and \u2013 9: an in vitro study. Mol Vis 17:3406\u20133414","journal-title":"Mol Vis"},{"key":"11425_CR79","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/989560","volume":"2015","author":"GT Gonzalez-Mateo","year":"2015","unstructured":"Gonzalez-Mateo GT, Aguirre AR, Loureiro J et al (2015) Rapamycin protects from type-I peritoneal membrane failure inhibiting the angiogenesis, lymphangiogenesis, and endo-MT. Biomed Res Int 2015:989560","journal-title":"Biomed Res Int"},{"issue":"11","key":"11425_CR80","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1161\/STROKEAHA.123.044108","volume":"54","author":"L Li","year":"2023","unstructured":"Li L, Ren AA, Gao S et al (2023) Mtorc1 inhibitor rapamycin inhibits growth of cerebral cavernous malformation in adult mice. Stroke 54(11):2906\u20132917","journal-title":"Stroke"},{"key":"11425_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-015-0003-0","volume":"12","author":"T Furihata","year":"2015","unstructured":"Furihata T, Kawamatsu S, Ito R et al (2015) <article-title update=\"added\">Hydrocortisone enhances the barrier properties of HBMEC\/ci\u03b2, a brain microvascular endothelial cell line, through mesenchymal-to-endothelial transition-like effects. Fluids Barriers CNS 12:7","journal-title":"Fluids Barriers CNS"},{"issue":"4","key":"11425_CR82","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10143-015-0699-y","volume":"39","author":"S Kar","year":"2016","unstructured":"Kar S, Baisantry A, Nabavi A, Bertalanffy H (2016) Role of delta-notch signaling in cerebral cavernous malformations. Neurosurg Rev 39(4):581\u2013589","journal-title":"Neurosurg Rev"},{"issue":"8","key":"11425_CR83","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1161\/CIRCRESAHA.117.309930","volume":"121","author":"SI Cunha","year":"2017","unstructured":"Cunha SI, Magnusson PU, Dejana E, Lampugnani MG (2017) Deregulated TGF-beta\/BMP signaling in vascular malformations. Circ Res 121(8):981\u2013999","journal-title":"Circ Res"},{"issue":"2","key":"11425_CR84","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1080\/15548627.2015.1125073","volume":"12","author":"S Marchi","year":"2016","unstructured":"Marchi S, Retta SF, Pinton P (2016) Cellular processes underlying cerebral cavernous malformations: autophagy as another point of view. Autophagy 12(2):424\u2013425","journal-title":"Autophagy"},{"issue":"4","key":"11425_CR85","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.stem.2020.02.013","volume":"26","author":"PY Chen","year":"2020","unstructured":"Chen PY, Qin L, Li G et al (2020) Smooth muscle cell reprogramming in aortic aneurysms. Cell Stem Cell 26(4):542\u2013557e11","journal-title":"Cell Stem Cell"},{"issue":"7","key":"11425_CR86","doi-asserted-by":"publisher","first-page":"712","DOI":"10.15252\/emmm.201506181","volume":"8","author":"PY Chen","year":"2016","unstructured":"Chen PY, Qin L, Li G, Tellides G, Simons M (2016) Smooth muscle FGF\/TGFbeta cross talk regulates atherosclerosis progression. EMBO Mol Med 8(7):712\u2013728","journal-title":"EMBO Mol Med"},{"issue":"8","key":"11425_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12081795","volume":"12","author":"JY Jeong","year":"2024","unstructured":"Jeong JY, Bafor AE, Freeman BH et al (2024) Pathophysiology in brain arteriovenous malformations: focus on endothelial dysfunctions and endothelial-to-mesenchymal transition. Biomedicines 12(8):1609","journal-title":"Biomedicines"},{"issue":"1","key":"11425_CR88","first-page":"180","volume":"19","author":"C Lou","year":"2023","unstructured":"Lou C, Li T (2023) Long non-coding RNA SENCR alleviates endothelial-to-mesenchymal transition via targeting miR-126a. Arch Med Sci 19(1):180\u2013188","journal-title":"Arch Med Sci"},{"issue":"1","key":"11425_CR89","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41420-022-01092-4","volume":"8","author":"C Ni","year":"2022","unstructured":"Ni C, Qiu H, Zhang S et al (2022) CircRNA-3302 promotes endothelial-to-mesenchymal transition via sponging miR-135b-5p to enhance KIT expression in Kawasaki disease. Cell Death Discov 8(1):299","journal-title":"Cell Death Discov"},{"key":"11425_CR90","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pharmthera.2018.11.003","volume":"196","author":"S Xu","year":"2019","unstructured":"Xu S, Kamato D, Little PJ et al (2019) Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics. Pharmacol Ther 196:15\u201343","journal-title":"Pharmacol Ther"},{"issue":"9","key":"11425_CR91","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1161\/ATVBAHA.118.311276","volume":"38","author":"MS Hulshoff","year":"2018","unstructured":"Hulshoff MS, Xu X, Krenning G, Zeisberg EM (2018) Epigenetic regulation of endothelial-to-mesenchymal transition in chronic heart disease. Arterioscler Thromb Vasc Biol 38(9):1986\u20131996","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"11425_CR92","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/cvr\/cvv015","volume":"105","author":"X Xu","year":"2015","unstructured":"Xu X, Tan X, Tampe B et al (2015) Epigenetic balance of aberrant Rasal1 promoter methylation and hydroxymethylation regulates cardiac fibrosis. Cardiovasc Res 105(3):279\u201391","journal-title":"Cardiovasc Res"},{"issue":"9","key":"11425_CR93","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s42255-019-0102-3","volume":"1","author":"PY Chen","year":"2019","unstructured":"Chen PY, Qin L, Li G et al (2019) Endothelial TGF-beta signalling drives vascular inflammation and atherosclerosis. Nat Metab 1(9):912\u2013926","journal-title":"Nat Metab"},{"key":"11425_CR94","doi-asserted-by":"publisher","first-page":"584839","DOI":"10.3389\/fnagi.2020.584839","volume":"12","author":"M Li","year":"2020","unstructured":"Li M, Liu Q, Yang J et al (2020) Metabolic disorder of extracellular matrix mediated by decorin upregulation is associated with brain arteriovenous malformation diffuseness. Front Aging Neurosci 12:584839","journal-title":"Front Aging Neurosci"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11425-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11425-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11425-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T14:02:30Z","timestamp":1767708150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11425-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11425"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11425-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"258"}}